The estimated Net Worth of Geoffrey M. Curtis is at least $15 Million dollars as of 1 April 2021. Mr. Curtis owns over 70,739 units of Horizon Therapeutics Plc stock worth over $6,126,103 and over the last 9 years he sold HZNP stock worth over $8,877,850. In addition, he makes $0 as Executive Vice President - Corporate Affairs and Chief Communications Officer at Horizon Therapeutics Plc.
Geoffrey has made over 9 trades of the Horizon Therapeutics Plc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 70,739 units of HZNP stock worth $6,614,804 on 1 April 2021.
The largest trade he's ever made was selling 70,739 units of Horizon Therapeutics Plc stock on 1 April 2021 worth over $6,614,804. On average, Geoffrey trades about 9,806 units every 46 days since 2016. As of 1 April 2021 he still owns at least 52,675 units of Horizon Therapeutics Plc stock.
You can see the complete history of Mr. Curtis stock trades at the bottom of the page.
Geoffrey M. Curtis serves as Executive Vice President - Corporate Affairs, Chief Communications Officer of the Company. Prior to that, from May 2017 he served as our senior vice president of corporate affairs and chief communications officer, and as group vice president of corporate communications from December 2015, when he joined Horizon. From May 2012 until April 2015, Mr. Curtis served as senior vice president at Edelman Public Relations and, as part of its National Health Media Team, he led media strategy and execution for a large portfolio of pharmaceutical, biotech and medical device clients. Prior to that, Mr. Curtis was group director of the media practice at WCG, a marketing and communications firm and part of W20 Group, from July 2006 until May 2012 and held a similar role at GCI Group from March 2004 until July 2006. Prior to joining GCI, Mr. Curtis served as a public affairs manager in the Pharmaceutical Products Division at Abbott, where he led internal and external communications programs for the immunology, neuroscience and oncology franchises.
Geoffrey Curtis is 45, he's been the Executive Vice President - Corporate Affairs and Chief Communications Officer of Horizon Therapeutics Plc since 2018. There are 21 older and 2 younger executives at Horizon Therapeutics Plc. The oldest executive at Horizon Therapeutics Plc is William Daniel, 67, who is the Independent Director.
Geoffrey's mailing address filed with the SEC is C/O HORIZON THERAPEUTICS PLC, CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD, DUBLIN, L2, 4.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over $454,905,275 worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth $58,823,653 . The most active insiders traders include Jeff Himawan, Woodlands Health Ventures F..., and Jean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of $12,248,018. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth $351,691.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: